Page 1 | Search Results | Blood Advances | American Society of Hematology

1-20 of 1547

Sort by

Sort Order Select

Journal Articles

A phase 2 study of obinutuzumab combined with lenalidomide in previously untreated high tumor burden follicular lymphoma

Blood Adv (2025) 9 (17): 4396–4404.

https://doi.org/10.1182/bloodadvances.2025016483

Published: 2025

Includes: Supplemental data

Journal Articles

Evaluation of in vivo CAR transgene levels in tisagenlecleucel-treated patients with relapsed/refractory B-ALL and DLBCL

Rakesh Awasthi, Stephan A. Grupp, Edward R. Waldron, Gregory A. Yanik, Constantine S. Tam, Susana Rives, Joseph P. McGuirk, Michael A. Pulsipher, Ulrich Jaeger, Gary D. Myers, Peter Borchmann, Stephen J. Schuster, Heather E. Stefanski, Michael R. Bishop, Abhijit Chakraborty, Aisha Masood, André Baruchel, Edmund K. Waller

Blood Adv (2025) 9 (17): 4405–4414.

https://doi.org/10.1182/bloodadvances.2024014995

Published: 2025

Includes: Supplemental data

Journal Articles

Efficacy of MRD-triggered Anti-CD20 Retreatment in Patients with High-Risk Chronic Lymphocytic Leukemia: A Case Series

Ellinor Goergen, Sandra Robrecht, Rudy Ligtvoet, Kirsten Fischer, Barbara F. Eichhorst, Petra Langerbeins, Michael J Hallek

Blood Adv bloodadvances.2025017109.

https://doi.org/10.1182/bloodadvances.2025017109

Published: 2025

Journal Articles

Monoclonal gammopathy defines distinct clinical subsets in Chronic Lymphocytic Leukemia across therapeutic eras

Yuting Yan, Bolin Yuan, Tonglu Qiu, Guoqiang Liu, Weihao Chen, Tingyu Wang, Ying Yu, Wenjie Xiong, Gang An, Dehui Zou, Jian-Yong Li, Liang Wang, Shuhua Yi

Blood Adv bloodadvances.2025017057.

https://doi.org/10.1182/bloodadvances.2025017057

Published: 2025

Includes: Supplemental data

Journal Articles

Identification of four autophagy-related genetic variants as risk factors for chronic lymphocytic leukemia

Antonio José Cabrera-Serrano, José Manuel Sánchez-Maldonado, Juan José Rodríguez-Sevilla, Fernando Jesús Reyes-Zurita, Rosa Collado, Anna Puiggros, Elena Cornejo-Calvo, Paloma García, Rob Ter Horst, Yolanda Benavente, Andrés Jerez, Stefano Landi, Blanca Espinet, Rossana Maffei, Miguel Ángel López-Nevot, Silvia Ramos-Campoy, Carmen González-Olmedo, Tzu-Hua Chen-Liang, Victor Moreno, Fatin Jannus, Rafael Marcos-Gragera, María Carretero-Fernández, Belém Sampaio-Marques, Irene Gámez, María Garcia-Alvarez, Nicola J. Camp, Trinidad Dierssen-Sotos, Joanna Kamaso, Eva María Pérez, Aaron D Norman, Mario Luppi, Yang Li, Miguel Alcoceba, Daniele Campa, Silvia de Sanjose, Roberto Marasca, Prof, Paula Ludovico, Alyssa Ione Clay-Gilmour, Federico Canzian, Marian Ibañez, Mihai G Netea, James McKay, Delphine Casabonne, Sonja I. Berndt, Susan L. Slager, Juan Sainz

Blood Adv bloodadvances.2025017345.

https://doi.org/10.1182/bloodadvances.2025017345

Published: 2025

Includes: Supplemental data

Journal Articles

BRCA1/2 impact on the development of implant-associated lymphoma in women with breast cancer and textured implants

Paola Ghione, Diana Mandelker, Maria Arcila, Venkatraman Seshan, Mary Beth Terry, Joseph Vijai, Peter Cordeiro, Chad Vanderbilt, Joyce Pressley, Alexander Chan, Natasha Galasso, Ahmet Dogan, Gilles Salles, Daphne de Jong, Flora van Leeuwen, Steven Horwitz

Blood Adv (2025) 9 (17): 4436–4443.

https://doi.org/10.1182/bloodadvances.2025016810

Published: 2025

Journal Articles

Too soon to reject immunoglobulin replacement in CLL

Stephen Opat, Ross Salvaris

Blood Adv bloodadvances.2025018034.

https://doi.org/10.1182/bloodadvances.2025018034

Published: 2025

Journal Articles

Risk of synchronous and second primary malignancies in multiple myeloma transplant-ineligible treated with lenalidomide

Thomas Systchenko, Ialy Nsiala, Arthur Bobin, Hélène Gardeney, Carine Motard, Gaelle Olivier, Florence Borde, Anne Corby, Christophe Roul, Emmanuel Fleck, Guillaume Denis, Céline Dieval, Philippe Mottaz, Annick Boscagli, Gautier Defossez, Xavier Leleu

Blood Adv bloodadvances.2025016625.

https://doi.org/10.1182/bloodadvances.2025016625

Published: 2025

Includes: Supplemental data

Journal Articles

Peripheral neuropathy and BTKis in Waldenström: a response?

Chiara Briani, Bruno Ferrero, Alessandro Salvalaggio, Simone Ragaini, Enrico Amaducci, Irene Dogliotti, Andrea Visentin, Simone Ferrero

Blood Adv (2025) 9 (16): 4319–4320.

https://doi.org/10.1182/bloodadvances.2025016734

Published: 2025

Journal Articles

USP7 alterations are associated with a poor survival in pediatric T-cell Acute Lymphoblastic Leukemia

Unai Illarregi, Angela Gutierrez-Camino, Ricardo Lopez-Almaraz, Javier Arzuaga-Mendez, Manuel Ramírez-Orellana, Emily Ashcraft, Daniel Sinnett, Itziar Astigarraga, Idoia Martin-Guerrero, Elixabet Lopez-Lopez

Blood Adv bloodadvances.2025017219.

https://doi.org/10.1182/bloodadvances.2025017219

Published: 2025

Includes: Supplemental data

Journal Articles

SOX11 Modulates BCR Signaling Through the PAX5/CD19 Axis for Therapeutic Targeting in BTK Resistant Mantle Cell Lymphoma

Rudra Prasad Dutta, Heng-Huan Lee, Violetta V. Leshchenko, Ravi Prakash Shukla, Fangfang Yan, Yang Liu, H Ümit Kaniskan, Xing Qiu, Jian Jin, Lapo Alinari, Michael L Wang, Samir Parekh

Blood Adv bloodadvances.2025016801.

https://doi.org/10.1182/bloodadvances.2025016801

Published: 2025

Includes: Supplemental data

Journal Articles

An Analysis of Diagnostic Metabolomic Profiles Associated with Hepatotoxicity During Childhood ALL Induction Therapy

Blood Adv bloodadvances.2025016978.

https://doi.org/10.1182/bloodadvances.2025016978

Published: 2025

Includes: Supplemental data

Journal Articles

Expression of HERV-K and embryonic genes in chronic lymphocytic leukemia and their association with therapy regimens

Blood Adv (2025) 9 (16): 4265–4278.

https://doi.org/10.1182/bloodadvances.2024014181

Published: 2025

Includes: Supplemental data

Journal Articles

Real-world evidence of duvelisib and romidepsin in relapsed/refractory peripheral and cutaneous T-cell lymphomas

Blood Adv (2025) 9 (16): 4286–4305.

https://doi.org/10.1182/bloodadvances.2025016347

Published: 2025

Includes: Supplemental data

Journal Articles

Avoid burning bridges before CAR-T therapy in myeloma

Swetha Reddi, Rahul Banerjee

Blood Adv (2025) 9 (16): 4232–4234.

https://doi.org/10.1182/bloodadvances.2025016774

Published: 2025

Journal Articles

One for the ages: impact of age on international prognostic indices in lymphoid cancer

Christian Brieghel, Emelie Curovic Rotbain, Jelena Jelicic, Sigrun Thorsteinsdottir, Peter de Nully Brown, Carsten Utoft Niemann

Blood Adv (2025) 9 (16): 4260–4264.

https://doi.org/10.1182/bloodadvances.2025016534

Published: 2025

Includes: Supplemental data

Journal Articles

Ectopic expression of BEX genes in T-cell Acute Lymphoblastic Leukemia

Julie Quessada, Mathis Nozais, Clémence Grosjean, Charlotte Savey, Saran Pankaew, Sara Allelova, Delphine Potier, Marie Loosveld, Dominique Payet-Bornet

Blood Adv bloodadvances.2024015174.

https://doi.org/10.1182/bloodadvances.2024015174

Published: 2025

Includes: Supplemental data

Journal Articles

New Comorbidity Index Associated with Survival After Chimeric Antigen Receptor T Cell Therapy for Large B-Cell Lymphoma

Blood Adv bloodadvances.2024015599.

https://doi.org/10.1182/bloodadvances.2024015599

Published: 2025

Includes: Supplemental data

Journal Articles

Phase 2 Study of Relmacabtagene Autoleucel (CD19 CAR-T) for Relapsed/Refractory Mantle Cell Lymphoma in Chinese Adults

Blood Adv bloodadvances.2024015763.

https://doi.org/10.1182/bloodadvances.2024015763

Published: 2025

Includes: Supplemental data

Journal Articles

Non-DLBCL Monomorphic and Hodgkin Lymphoma PTLD: Clinical Insights and Treatment Strategies

Suheil Albert Atallah-Yunes, Arushi Khurana, Thomas M. Habermann

Blood Adv bloodadvances.2025016930.

https://doi.org/10.1182/bloodadvances.2025016930

Published: 2025

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

A phase 2 study of obinutuzumab combined with lenalidomide in previously untreated high tumor burden follicular lymphoma

Evaluation of in vivo CAR transgene levels in tisagenlecleucel-treated patients with relapsed/refractory B-ALL and DLBCL

Efficacy of MRD-triggered Anti-CD20 Retreatment in Patients with High-Risk Chronic Lymphocytic Leukemia: A Case Series

Monoclonal gammopathy defines distinct clinical subsets in Chronic Lymphocytic Leukemia across therapeutic eras

Identification of four autophagy-related genetic variants as risk factors for chronic lymphocytic leukemia

BRCA1/2 impact on the development of implant-associated lymphoma in women with breast cancer and textured implants

Too soon to reject immunoglobulin replacement in CLL

Risk of synchronous and second primary malignancies in multiple myeloma transplant-ineligible treated with lenalidomide

Peripheral neuropathy and BTKis in Waldenström: a response?

USP7 alterations are associated with a poor survival in pediatric T-cell Acute Lymphoblastic Leukemia

SOX11 Modulates BCR Signaling Through the PAX5/CD19 Axis for Therapeutic Targeting in BTK Resistant Mantle Cell Lymphoma

An Analysis of Diagnostic Metabolomic Profiles Associated with Hepatotoxicity During Childhood ALL Induction Therapy

Expression of HERV-K and embryonic genes in chronic lymphocytic leukemia and their association with therapy regimens

Real-world evidence of duvelisib and romidepsin in relapsed/refractory peripheral and cutaneous T-cell lymphomas

Avoid burning bridges before CAR-T therapy in myeloma

One for the ages: impact of age on international prognostic indices in lymphoid cancer

Ectopic expression of BEX genes in T-cell Acute Lymphoblastic Leukemia

New Comorbidity Index Associated with Survival After Chimeric Antigen Receptor T Cell Therapy for Large B-Cell Lymphoma

Phase 2 Study of Relmacabtagene Autoleucel (CD19 CAR-T) for Relapsed/Refractory Mantle Cell Lymphoma in Chinese Adults

Non-DLBCL Monomorphic and Hodgkin Lymphoma PTLD: Clinical Insights and Treatment Strategies

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only